Skip to content
polio vaccine

File:Poliodrops.jpg · Wikimedia Commons · See Wikimedia Commons

EntityQ1519099· pop 49· linked from 755 articles

polio vaccine

Sign in to save

Also known as poliovirus vaccine, poliomyelitis vaccine, live poliovirus vaccine, poliovirus vaccines, polio vaccines

vaccine to prevent poliomyelitis

Key facts

Target
Poliomyelitis
Vaccine type
IPV: inactivated, OPV: attenuated, nOPV2: attenuated, genetically stabilised
Trade names
Ipol, Poliovax, others
Ahfs drugs com
Monograph
Medlineplus
a601177
License data
United States</span>"}]]}'>US DailyMed : Ipol
Pregnancy category
Australia</span>"}]]}'>AU : B2
Routes of administration
IPV: parenteral , OPV: oral
Atc code
J07BF01 ( WHO ) J07BF02 ( WHO ) J07BF03 ( WHO ) J07BF04 ( WHO )
Legal status
United States</span>"}]]}'>US : ℞-only
Cas number
1008119-78-5
Drugbank
DB10796 DB10797
Chemspider
None
Kegg
D05543

via Wikipedia infobox

Wikidata facts

Subclass of
vaccine
Image
Poliodrops.jpg
Show 7 more facts
Commons category
Polio vaccine
vaccine for
poliomyelitis
discoverer or inventor
Jonas Salk
location of creation
University of Pittsburgh
inception
1952-00-00
publication date
1955-04-12
Sources (4)

via Wikidata · CC0

~40 min read

Encyclopedic overview

Polio vaccine is a vaccine used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization (WHO) recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018.

The inactivated polio vaccines are very safe. Mild redness or pain may occur at the site of injection. Oral polio vaccines cause about three cases of vaccine-associated paralytic poliomyelitis per million doses given. This compares with 5,000 cases per million who are paralysed following a polio infection. Both types of vaccine are generally safe to give during pregnancy and in those who have HIV/AIDS, but are otherwise well. However, the emergence of circulating vaccine-derived poliovirus (cVDPV), a form of the vaccine virus that has reverted to causing poliomyelitis, has led to the development of novel oral polio vaccine type 2 (nOPV2), which aims to make the vaccine safer and thus stop further outbreaks of cVDPV.

Excerpted from Wikipedia’s “polio vaccine” article, available under the CC BY-SA 4.0 licence.

Gallery (12)